Inventor · disambiguated record
Sabine Lang
Also filed as: LANG SABINE
0 granted patents·8 pending applications·0 citations·filing 2014–2020
Files withHOFFMANN LA ROCHE8
Top patents by PatentIndex Score
8 records- 0168US2021138065A1COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A CD79b ANTIBODY-DRUG CONJUGATEHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 0258US2014356352A1COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A CD79b ANTIBODY-DRUG CONJUGATEHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 0357US2018344848A1COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A CD79b ANTIBODY-DRUG CONJUGATEHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 0456US2020325225A1Combination therapy with targeted 4-1bb (cd137) agonistsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 0555US2018133315A1COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A CD79b ANTIBODY-DRUG CONJUGATEHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 0649US2015010540A1Combination therapy of an afucosylated cd20 antibody with a cd22 antibody-drug conjugateHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 0748US2020392237A1Combination therapy with targeted OX40 agonistsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 0843US2017306040A1Combination therapy of an afucosylated cd20 antibody with a cd22 antibody-drug conjugateHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sabine Lang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →